Clinical trial Recruiting at 1 site Phase1; Phase2 Interventional Ages 18 and up

Virtual group speech therapy for head and neck cancer patients

Official title: Impacts of an Innovative Patient-partner-guided Virtual Group Speech Pathology Intervention Model to Prevent Swallowing Disorders in Patients Treated With Chemoradiotherapy for Head and Neck Cancer

Run by Centre hospitalier de l'Université de Montréal (CHUM) · NCT05621889 · Data updated 2026-11-12

This study tests a new online group speech therapy program for head and neck cancer patients to see if it helps them stick to their treatment and avoid swallowing problems during their care.

Quick facts

PhasePhase1; Phase2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment76 (estimated)
SponsorCentre hospitalier de l'Université de Montréal (CHUM)
Academic / other
Drugs / interventionsradiation
Locations1 site (Montreal, Quebec)
StatusRecruiting
StartedJune 2, 2023
Main results expectedJanuary 2026
Study endsJanuary 2026
Registry record updatedMarch 21, 2025
Trial IDNCT05621889 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older with a diagnosis of head or neck cancer who are scheduled to receive curative chemoradiotherapy.

Probably not a fit

Patients with remote metastases, previous total laryngectomy, or severe dysphagia may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project investigates an innovative virtual group speech therapy intervention, known as the eG2 Intervention, designed by speech-language pathologists at the Centre hospitalier de l'Université de Montréal. The intervention aims to enhance therapeutic adherence and prevent dysphagia in patients undergoing chemoradiotherapy for head and neck cancer. It uniquely incorporates a patient partner to guide the group sessions, improving accessibility and quality of care while optimizing healthcare resources.

Why it matters

Potential benefit: If successful, this intervention could significantly improve the quality of life for head and neck cancer patients by reducing the incidence of dysphagia.

How similar studies have gone: While this approach is innovative, similar virtual group interventions have shown promise in other areas of rehabilitation, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults ≥ 18 years of age with a diagnosis of head or neck cancer
* Chemoradiotherapy treatments planned for curative purposes
* Planned external radiation therapy dose of at least ≥60 Grays
* Sufficient proficiency in French to complete self-reported questionnaires

Exclusion Criteria:

* Remote metastases
* Previous or planned total laryngectomy
* Previous moderate/severe dysphagia known and/or evaluated by speech therapy
* Diagnosis of a second synchronous cancer at the time of study enrollment
* History of prior radiation therapy to the head and neck area
* Have a cognitive impairment (diagnosed or suspected) that may significantly interfere with participation in the intervention and various measurement procedures.

Where it's running

  • Centre Hospitalier de l'Université de Montréal
    Montreal, Quebec, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.